Leveraging Computational Design, Miniaturization, & Microfluidics to Accelerate the Discovery of Therapeutic Proteins
Time: 1:30 pm
day: Conference Day Two
Details:
Integration of physical and digital automations to advance lead discovery process, a case study highlighting the impact of these will be presented:
- Leveraging ML/sequence clustering, Next-Gen sequencing to maximize in vitro and in vivo discovery campaigns
- Discovery of de novo binders to complex receptor complexes
- uHT production and characterization approaches to accelerating lead selection
